Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial.
Thus KA, De Groot-Kruseman HA, Winkler-Seinstra P, Fiocco M, Segers H, Van den Bos C, Van der Sluis IM, Tissing WJE, Veening MA, Zwaan CM, Van Tilburg CM, Pieters R, Bierings M. Thus KA, et al. Among authors: van den bos c. Haematologica. 2025 Jan 1;110(1):47-54. doi: 10.3324/haematol.2024.285428. Haematologica. 2025. PMID: 39113674 Free PMC article. Clinical Trial.
Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients.
Sassen SD, Mathôt RA, Pieters R, Kloos RQ, de Haas V, Kaspers GJ, van den Bos C, Tissing WJ, Te Loo M, Bierings MB, Kollen WJ, Zwaan CM, van der Sluis IM. Sassen SD, et al. Among authors: van den bos c, van der sluis im. Haematologica. 2017 Mar;102(3):552-561. doi: 10.3324/haematol.2016.149195. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28250007 Free PMC article.
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Tong WH, Pieters R, Kaspers GJ, te Loo DM, Bierings MB, van den Bos C, Kollen WJ, Hop WC, Lanvers-Kaminsky C, Relling MV, Tissing WJ, van der Sluis IM. Tong WH, et al. Among authors: van den bos c, van der sluis im. Blood. 2014 Mar 27;123(13):2026-33. doi: 10.1182/blood-2013-10-534347. Epub 2014 Jan 21. Blood. 2014. PMID: 24449211 Free PMC article. Clinical Trial.
Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SM, Bierings MB, van den Bos C, Zwaan CM, Thygesen HH, Tissing WJ, Veening MA, Pieters R, van den Akker EL. Warris LT, et al. Among authors: van den heuvel eibrink mm, van den bos c, van den akker el. J Clin Oncol. 2016 Jul 1;34(19):2287-93. doi: 10.1200/JCO.2015.66.0761. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161966 Clinical Trial.
Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
Warris LT, van den Akker EL, Bierings MB, van den Bos C, Zwaan CM, Sassen SD, Tissing WJ, Veening MA, Pieters R, van den Heuvel-Eibrink MM. Warris LT, et al. Among authors: van den heuvel eibrink mm, van den bos c, van den akker el. PLoS One. 2016 Jun 30;11(6):e0158225. doi: 10.1371/journal.pone.0158225. eCollection 2016. PLoS One. 2016. PMID: 27362350 Free PMC article. Clinical Trial.
Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT, van den Akker EL, Aarsen FK, Bierings MB, van den Bos C, Tissing WJ, Sassen SD, Veening MA, Zwaan CM, Pieters R, van den Heuvel-Eibrink MM. Warris LT, et al. Among authors: van den heuvel eibrink mm, van den bos c, van den akker el. Psychoneuroendocrinology. 2016 Oct;72:190-5. doi: 10.1016/j.psyneuen.2016.07.006. Epub 2016 Jul 11. Psychoneuroendocrinology. 2016. PMID: 27448086
Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
Warris LT, van den Akker ELT, Bierings MB, van den Bos C, Aarsen FK, Zwaan MC, Tissing WJE, Veening MA, Pieters R, van den Heuvel-Eibrink MM. Warris LT, et al. Among authors: van den heuvel eibrink mm, van den bos c, van den akker elt. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26679. Epub 2017 Jun 9. Pediatr Blood Cancer. 2017. PMID: 28598548
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R. van der Sluis IM, et al. Among authors: van den bos c. Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4. Pediatr Blood Cancer. 2018. PMID: 29727043 Clinical Trial.
Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients.
Sassen SDT, Mathôt RAA, Pieters R, de Haas V, Kaspers GJL, van den Bos C, Tissing WJE, Te Loo DMWW, Bierings MB, van Westreenen M, van der Sluis IM, Zwaan CM. Sassen SDT, et al. Among authors: van den bos c, van westreenen m, van der sluis im. Clin Infect Dis. 2020 Nov 5;71(8):e281-e288. doi: 10.1093/cid/ciz1163. Clin Infect Dis. 2020. PMID: 31790556
129 results